U.S. markets closed

Guardant Health, Inc. (GH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
112.84+3.07 (+2.80%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Double Moving Average Crossover

Double Moving Average Crossover

Previous Close109.77
Open110.28
Bid105.00 x 800
Ask127.84 x 800
Day's Range108.12 - 114.49
52 Week Range74.31 - 181.07
Volume1,144,465
Avg. Volume979,082
Market Cap11.41B
Beta (5Y Monthly)0.47
PE Ratio (TTM)N/A
EPS (TTM)-3.39
Earnings DateAug 04, 2021 - Aug 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est178.30
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Exact Sciences' First-Quarter Results Show Its Strength Under Pressure
    Motley Fool

    Exact Sciences' First-Quarter Results Show Its Strength Under Pressure

    Despite ongoing pandemic-related headwinds, the medical diagnostic test maker's revenue grew. So how will it perform as those headwinds dissipate?

  • 3 Cathie Wood Stocks for a $150 Billion Market That's Just Forming
    Motley Fool

    3 Cathie Wood Stocks for a $150 Billion Market That's Just Forming

    Cathie Wood has gained notoriety from making some seemingly outlandish calls on stocks and for being right. One of her less controversial projections is around preventative cancer screening. Specifically, she and her team believe liquid-biopsy screening for cancer could grow to a $150 billion market as the cost of tests drop.

  • Guardant Health Inc (GH) Q1 2021 Earnings Call Transcript
    Motley Fool

    Guardant Health Inc (GH) Q1 2021 Earnings Call Transcript

    Thank you for standing by, and welcome to the Guardant Health Q1 2021 Earnings Call. Earlier today, Guardant Health released financial results for the quarter ended March 31, 2021. Joining me today from Guardant is Helmy Eltoukhy, Chief Executive Officer; AmirAli Talasaz, President; and Mike Bell, Chief Financial Officer.